These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10081682)

  • 1. Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.
    McDonald LC; Garza LR; Jarvis WR
    Emerg Infect Dis; 1999; 5(1):143-6. PubMed ID: 10081682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
    Coombs GW; Kay ID; Steven RA; Pearman JW; Bertolatti D; Grubb WB
    J Clin Microbiol; 1999 Apr; 37(4):1229-30. PubMed ID: 10215453
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment and control of vancomycin resistant enterococci.
    Fraise AP
    J Antimicrob Chemother; 1996 Nov; 38(5):753-6. PubMed ID: 8961044
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci: pervasive and persistent pathogens.
    Boyce JM
    Infect Control Hosp Epidemiol; 1995 Dec; 16(12):676-9. PubMed ID: 8683084
    [No Abstract]   [Full Text] [Related]  

  • 5. Study to determine the ability of clinical laboratories to detect antimicrobial-resistant Enterococcus spp. in Buenos Aires, Argentina.
    Cookson ST; Lopardo H; Marin M; Arduino R; Rial MJ; Altschuler M; Galanternik L; Swenson JM; Tokars JI; Jarvis WR
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):107-9. PubMed ID: 9368087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective isolation of vancomycin-resistant enterococci.
    van Horn KG; Gedris CA; Rodney KM
    J Clin Microbiol; 1996 Apr; 34(4):924-7. PubMed ID: 8815109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
    Simonsen GS; Andersen BM; Digranes A; Harthug S; Jacobsen T; Lingaas E; Natås OB; Olsvik O; Ringertz SH; Skulberg A; Syversen G; Sundsfjord A
    Scand J Infect Dis; 1998; 30(5):465-8. PubMed ID: 10066045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin resistant Enterococci in a tertiary care hospital in Mumbai.
    De A; Bindlish A; Kumar S; Mathur M
    Indian J Med Microbiol; 2009; 27(4):375-6. PubMed ID: 19736416
    [No Abstract]   [Full Text] [Related]  

  • 13. Vancomycin resistant enterococci healthcare associated infections.
    Orsi GB; Ciorba V
    Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Enterococcus spp isolated from community acquired infections and colonizations in Querétaro City, Mexico.
    Garcia-G MC; Leo-Amador GE; Avila-Morales J; Zaldívar-Lelo de Larrea G; Sanchez-Corona J
    Am J Infect Control; 2014 May; 42(5):578-80. PubMed ID: 24773802
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):289-91. PubMed ID: 8598826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM
    J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.
    Shay DK; Goldmann DA; Jarvis WR
    Pediatr Clin North Am; 1995 Jun; 42(3):703-16. PubMed ID: 7761148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.
    Slaughter S; Hayden MK; Nathan C; Hu TC; Rice T; Van Voorhis J; Matushek M; Franklin C; Weinstein RA
    Ann Intern Med; 1996 Sep; 125(6):448-56. PubMed ID: 8779456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.